A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
Clinical trial NCT05871541 · COMPLETED
Trial details
- NCT number
- NCT05871541
- Sponsor
- Immorna Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2024-03-25
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.